MALDI Mass Spectrometry Imaging Analysis of Pituitary Adenomas for Near-real-time Tumor Delineation.


David Calligaris, Daniel R Feldman, Isaiah Norton, Olutayo Olubiyi, Armen N Changelian, Revaz Machaidze, Matthew L Vestal, Edward R Laws, Ian F Dunn, Sandro Santagata, and Nathalie YR Agar. 2015. “MALDI Mass Spectrometry Imaging Analysis of Pituitary Adenomas for Near-real-time Tumor Delineation.” Proc Natl Acad Sci U S A, 112, 32, Pp. 9978-83. Copy at


We present a proof of concept study designed to support the clinical development of mass spectrometry imaging (MSI) for the detection of pituitary tumors during surgery. We analyzed by matrix-assisted laser desorption/ionization (MALDI) MSI six nonpathological (NP) human pituitary glands and 45 hormone secreting and nonsecreting (NS) human pituitary adenomas. We show that the distribution of pituitary hormones such as prolactin (PRL), growth hormone (GH), adrenocorticotropic hormone (ACTH), and thyroid stimulating hormone (TSH) in both normal and tumor tissues can be assessed by using this approach. The presence of most of the pituitary hormones was confirmed by using MS/MS and pseudo-MS/MS methods, and subtyping of pituitary adenomas was performed by using principal component analysis (PCA) and support vector machine (SVM). Our proof of concept study demonstrates that MALDI MSI could be used to directly detect excessive hormonal production from functional pituitary adenomas and generally classify pituitary adenomas by using statistical and machine learning analyses. The tissue characterization can be completed in fewer than 30 min and could therefore be applied for the near-real-time detection and delineation of pituitary tumors for intraoperative surgical decision-making.

Last updated on 01/04/2016